Paralos Bio
1 known investors
Paralos is developing a modular M13 phage drug delivery platform that creates phage-drug conjugates to concentrate therapeutic payloads at specific targets. The platform pairs programmable target binding with payload presentation to localize drug exposure and engineer delivery around the therapeutic window.
BiotechDeep Tech
Investors · 1
Frequently asked questions
- What does Paralos Bio do?
- Paralos is developing a modular M13 phage drug delivery platform that creates phage-drug conjugates to concentrate therapeutic payloads at specific targets. The platform pairs programmable target binding with payload presentation to localize drug exposure and engineer delivery around the therapeutic window.
- Who are Paralos Bio's investors?
- Paralos Bio's investors include Carbon Silicon.